These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 4905154)

  • 1. Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors.
    Clarkson B; Krakoff I; Burchenal J; Karnofsky D; Golbey R; Dowling M; Oettgen H; Lipton A
    Cancer; 1970 Feb; 25(2):279-305. PubMed ID: 4905154
    [No Abstract]   [Full Text] [Related]  

  • 2. E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children.
    Tallal L; Tan C; Oettgen H; Wollner N; McCarthy M; Helson L; Burchenal J; Karnofsky D; Murphy ML
    Cancer; 1970 Feb; 25(2):306-20. PubMed ID: 4905155
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of leukemia in USA. 2. L asparaginase in leukemia].
    Böttiger LE
    Lakartidningen; 1969 Jan; 66(5):455-60. PubMed ID: 5254602
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli].
    Kondrat'eva NA; Lorie IlI ; Kruglova GV; Vorob'ev AI; Koshel' IV
    Antibiotiki; 1977 Sep; 22(9):852-7. PubMed ID: 334060
    [No Abstract]   [Full Text] [Related]  

  • 5. [First results of the treatment of acute leukemia with L-asparaginase].
    Marmont A; Damasio E; Bordo D; Fazio F; Gori E; Rossi F
    Haematologica; 1970; 55(9):593-6. PubMed ID: 4996527
    [No Abstract]   [Full Text] [Related]  

  • 6. L-asparaginase.
    Capizzi RL; Bertino JR; Handschumacher RE
    Annu Rev Med; 1970; 21():433-44. PubMed ID: 4913953
    [No Abstract]   [Full Text] [Related]  

  • 7. A summary of the clinical status of asparaginase.
    Burchenal JH
    Recent Results Cancer Res; 1970; 33():350-4. PubMed ID: 5292724
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukemia and lymphoma.
    White LP
    Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
    [No Abstract]   [Full Text] [Related]  

  • 9. [Personal experience on the chemotherapy of leukemias and hematosarcomas].
    Mathé G; Schneider M; Schwarzenberg L; Cattan A; Amiel JL; Schlumberger JR
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):245-54. PubMed ID: 4874537
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro test for sensitivity of leukemic cells to L-asparaginase.
    Schrek R; Dolowy WC
    Cancer Res; 1971 May; 31(5):523-6. PubMed ID: 4932205
    [No Abstract]   [Full Text] [Related]  

  • 11. Some clinical observations on the treatment with L-asparaginase of the acute leukemias.
    Marmont AM; Damasio EE
    Recent Results Cancer Res; 1970; 33():296-315. PubMed ID: 4949165
    [No Abstract]   [Full Text] [Related]  

  • 12. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
    Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
    N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with L-asparaginase.
    Hamilton-Fairley G; Malpas JS; Galton DA
    Recent Results Cancer Res; 1970; 33():257-62. PubMed ID: 4949164
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1966 May; 116(21):468-71. PubMed ID: 4863533
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical and pharmacological studies with asparaginase in man.
    Ohnuma T; Holland JF; Freeman A; Sinks LF
    Cancer Res; 1970 Sep; 30(9):2297-305. PubMed ID: 4920133
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhibition of malignant human neoplasms with L-asparaginase].
    Oettgen HF; Schulten HK
    Klin Wochenschr; 1969 Jan; 47(2):65-71. PubMed ID: 4904782
    [No Abstract]   [Full Text] [Related]  

  • 17. L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia.
    Hill JM; Roberts J; Loeb E; Khan A; MacLellan A; Hill RW
    JAMA; 1967 Nov; 202(9):882-8. PubMed ID: 5234350
    [No Abstract]   [Full Text] [Related]  

  • 18. Depression of functional and antigenic plasma antithrombin III (AT-III) due to therapy with L-asparaginase.
    Liebman HA; Wada JK; Patch MJ; McGehee W
    Cancer; 1982 Aug; 50(3):451-6. PubMed ID: 7046902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [L-asparaginase--first specific cytostatic].
    Marquardt H
    Arzneimittelforschung; 1968 Nov; 18(11):1380-6. PubMed ID: 4885156
    [No Abstract]   [Full Text] [Related]  

  • 20. Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.
    Cridland MD
    Drugs; 1972; 3(5):331-51. PubMed ID: 4347084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.